(Q73359524)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12733850%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12733850%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

The Abrupt Cessation of Therapeutically Administered Sodium Oxybate (GHB) Does Not Cause Withdrawal Symptoms (English)

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

30 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12733850

30 December 2023

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12733850%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

http://www.tandfonline.com/doi/pdf/10.1081/CLT-120019128

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Journal of Toxicology: Clinical Toxicology

30 December 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12733850%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12733850%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12733850%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

131-135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12733850%20AND%20SRC:MED&resulttype=core&format=json

Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives

3 November 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Prevalence of narcolepsy symptomatology and diagnosis in the European general population.

30 December 2023

2

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Narcolepsy: a key role for hypocretins (orexins)

30 December 2023

3

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Hypocretin (orexin) deficiency in human narcolepsy.

30 December 2023

4

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Reduced number of hypocretin neurons in human narcolepsy

30 December 2023

5

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Significance of gamma-hydroxybutyric acid in the brain

30 December 2023

6

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.

30 December 2023

8

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.

30 December 2023

10

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Severe gamma-hydroxybutyrate withdrawal: a case report and literature review

30 December 2023

11

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Gamma-hydroxybutyrate withdrawal syndrome

30 December 2023

12

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies

30 December 2023

13

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence

30 December 2023

14

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Successful management of prolonged gamma-hydroxybutyrate and alcohol withdrawal.

30 December 2023

15

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid

30 December 2023

16

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

GHB: a new and novel drug of abuse

30 December 2023

17

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome.

30 December 2023

19

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Alcoholism: Clinical and Experimental Research

30 December 2023

20

23

1596

Addolorato G

1999

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Gamma-hydroxybutyric acid efficacy, potential abuse, and dependence in the treatment of alcohol addiction

30 December 2023

21

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence

30 December 2023

22

1 reference

https://api.crossref.org/works/10.1081/CLT-120019128

30 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12733850%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference